期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
全身麻醉深度对糖尿病患者术中血清CGRP、SP浓度的影响
1
作者 李怀亮 马崇皓 +2 位作者 张妙 李宇恒 郭政 《国际麻醉学与复苏杂志》 CAS 2022年第8期850-855,共6页
目的探讨不同麻醉深度对糖尿病患者血清降钙素基因相关肽(calcitonin gene-related peptide,CGRP)和P物质(substance P,SP)浓度的影响.方法选择全麻下行腹腔镜手术的患者78例,年龄42~70岁,性别不限,ASA分级Ⅰ、Ⅱ级.根据术前是否合并2... 目的探讨不同麻醉深度对糖尿病患者血清降钙素基因相关肽(calcitonin gene-related peptide,CGRP)和P物质(substance P,SP)浓度的影响.方法选择全麻下行腹腔镜手术的患者78例,年龄42~70岁,性别不限,ASA分级Ⅰ、Ⅱ级.根据术前是否合并2型糖尿病分为非糖尿病组(NDM组,40例)和糖尿病组(DM组,38例),两组患者再分别按随机数字表法分为非糖尿病浅麻醉组(LNDM组,20例)、非糖尿病深麻醉组(DNDM组,20例)、糖尿病浅麻醉组(LDM组,19例)、糖尿病深麻醉组(DDM组,19例).LNDM组、LDM组BIS值维持在50~59,DNDM组、DDM组BIS值维持在40~49.记录4组患者术前及术中情况(如麻醉时间、手术时间、停药后睁眼时间、PACU停留时间,麻醉药物用量,术中补液量、术中失血量、尿量等),记录4组患者术中不良心血管事件发生率及血管活性药物使用率,采用ELISA法测定4组患者术前和术毕时血清CGRP、SP浓度.结果与LNDM组比较:LDM组、DDM组术前血清CGRP、SP浓度均较低(P<0.05);DNDM组、DDM组丙泊酚用量增多(P<0.05)、停药后睁眼时间延长(P<0.05);DNDM组、LDM组、DDM组术毕血清CGRP、SP浓度均降低(P<0.05),DDM组术中不良心血管事件总发生率升高(P<0.05),术中血管活性药物总使用率升高(P<0.05).与DNDM组比较:LDM组、DDM组术前、术毕血清CGRP和SP浓度均较低(P<0.05);LDM组丙泊酚用量减少(P<0.05)、停药后睁眼时间缩短(P<0.05);DDM组术中不良心血管事件总发生率升高(P<0.05),DDM组术中血管活性药物使用率升高(P<0.05).与LDM组比较:DDM组丙泊酚用量增多(P<0.05)、停药后睁眼时间延长(P<0.05),术中不良心血管事件总发生率升高(P<0.05),术中血管活性药物使用率升高(P<0.05),术毕血清CGRP、SP浓度均降低(P<0.05).Logistic回归分析示术前血清CGRP[比值比(odds ratio,OR)0.78,95%CI 0.65~0.94,P=0.010]、SP浓度(OR0.98,95%CI0.97~0.10,P=0.020)是术中不良心血管事件发生率升高的影响因素.结论深麻醉是CGRP、SP降低的相关危险因素.糖尿病患者血清CGRP、SP浓度降低与深麻醉有关,糖尿病患者术中不良心血管事件发生率升高与血清CGRP、SP浓度降低有关. 展开更多
关键词 麻醉深度 糖尿病 术中不良心血管事件 辣椒素受 体降钙素基因相关肽 P物质
原文传递
Effects of electroacupuncture at 2 and 100 Hz on rat type 2 diabetic neuropathic pain and hyperalgesia-related protein expression in the dorsal root ganglion 被引量:12
2
作者 Xiao-fen HE Jun-jun WEI +2 位作者 Sheng-yun SHOU Jian-qiao FANG Yong-liang JIANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2017年第3期239-248,共10页
Objective: To investigate the analgesic effects of electroacupuncture (EA) at 2 and 100 Hz on type 2 diabetic neuropathic pain (DNP) and on the expressions of the P2X3 receptor and calcitonin gene-related peptide... Objective: To investigate the analgesic effects of electroacupuncture (EA) at 2 and 100 Hz on type 2 diabetic neuropathic pain (DNP) and on the expressions of the P2X3 receptor and calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG). Methods: Rat type 2 DNP was induced by a high calorie and high sugar diet fed for 7 weeks, plus a single intraperitoneal injection of streptozotocin (STZ) after 5 weeks. EA at 2 and 100 Hz was carried out once every day after 7 weeks for 7 consecutive days. Body weight, serum fasting insulin (FINS), fasting blood glucose (FBG), insulin sensitivity index (ISI), and paw withdrawal latency (PWL) were measured. The expressions of L4-L6 DRG P2X3 receptors and CGRP were assessed by immunofluorescence. Results: Type 2 DNP was successfully induced as shown by the increased body weight, FINS, and FBG, as well as the reduced ISI and PWL. Expressions of P2X3 receptors and CGRP in L4-L6 DRGs increased. EA at both 2 and 100 Hz relieved type 2 DNP, but the analgesic effect of EA was stronger at 2 Hz. P2X3 receptor expression decreased in L4-L6 DRGs following EA at 2 Hz and in L5 and L6 DRGs following EA at 100 Hz. EA at both 2 and 100 Hz down-regulated CGRP overexpression in L4-L6 DRGs. Conclusions: These findings indicate that EA at 2 Hz is a good option for the management of type 2 DNP. The EA effect may be related to its down-regulation of the overexpressions of the DRG P2X3 receptors and CGRP in this condition. 展开更多
关键词 ELECTROACUPUNCTURE Type 2 diabetic neuropathic pain Dorsal root ganglion P2X3 receptor Calcitoningene-related peptide
原文传递
Intermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease 被引量:14
3
作者 NI XianQiang ZHANG JinSheng +1 位作者 TANG ChaoShu QI YongFen 《Science China(Life Sciences)》 SCIE CAS 2014年第8期781-789,共9页
Intermedin(IMD)or adrenomedullin 2 is a novel peptide related to the calcitonin gene-related peptide(CGRP)family.Via calcitonin receptor-like receptor/receptor activity modifying proteins,the common receptor complexes... Intermedin(IMD)or adrenomedullin 2 is a novel peptide related to the calcitonin gene-related peptide(CGRP)family.Via calcitonin receptor-like receptor/receptor activity modifying proteins,the common receptor complexes of CGRP,IMD exerts a wide range of biological effects,especially regulation of cardiovascular homeostasis.Proteolytic processing of a larger IMD precursor yields a series of biologically active C-terminal fragments,IMD1–53,IMD1–47 and IMD8–47.IMD and its receptors are present in the cardiovascular system,and IMD is present at low levels in plasma.In the cardiovascular system,IMD has multiple functions such as regulation of blood pressure and cardiac function,pro-angiogenesis,endothelial barrier function protection,anti-oxidative stress,and anti-endoplasmic reticulum stress.IMD participates widely in the pathogenesis of atherosclerosis,hypertension,pulmonary arterial hypertension and vascular calcification.It is a vascular regulatory factor of homeostasis and a vital endogenous protective factor against vascular diseases. 展开更多
关键词 INTERMEDIN VESSEL HOMEOSTASIS vascular diseases
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部